Actigraphy Meets AI : A Digital Biomarker for Parkinson's Disease and Isolated REM Sleep Behaviour Disorder
Journal of Sleep Research · 2026-10 · 35 (5)
DOI: 10.1111/jsr.70396 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Sleep Research, online erschienen am 07.07.2026. Verfasst von Leonor Lopes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Parkinson Disease, REM Sleep Behavior Disorder, Actigraphy, Artificial Intelligence. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Isolated rapid eye movement (REM) sleep behaviour disorder (RBD) is an early stage of alpha‐synucleinopathies, such as Parkinson's disease (PD). Actigraphy is a promising tool for assessing rest‐activity patterns, however its diagnostic or predictive value in these disorders is understudied. This study evaluated AI‐based models applied to actigraphy data to improve the detection of PD and RBD, additionally exploring their capability to capture early neurodegenerative patterns in isolated RBD. We trained and evaluated machine learning models with extracted actigraphy features, a convolutional neural network and a pre‐trained transformer model—PAT—on two classification tasks: (1) distinguishing patients with PD from non‐neurodegenerative controls and (2) distinguishing patients with PD and RBD (PD‐RBD) from those without (PD‐noRBD). We tested the best‐performing model on patients with isolated RBD. PD‐RBD showed significantly altered actigraphy features compared to PD‐noRBD and controls. In PD versus control classification, the PAT model performed best (AUC = 0.937, sensitivity = 80.5%, specificity = 92.9%) followed by the neural network (AUC = 0.863) and machine learning (AUC = 0.840). In the PD‐RBD versus PD‐noRBD classification task, the PAT model again outperformed the other models (AUC = 0.956, sensitivity = 84.4% and specificity = 92.9%). For both tasks, the scores of isolated RBD patients fell between those of the comparison groups. AI‐based actigraphy models can distinguish PD patients from controls and identify subtypes with high sensitivity and specificity. This shows their potential as non‐invasive, scalable diagnostic tools and their relevance for identifying prodromal motor features, with future applications in predicting isolated RBD progression to PD. Validation in longitudinal cohorts remains necessary.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
- Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
- Schlaf-Wach-Epilepsie Zentrum, Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
ORCID-Profile: Leonor Lopes, Jan D Warncke, Irina Filchenko, Kuangyu Shi, Claudio L A Bassetti, Carolin Schäfer
Zitieren
APA
Lopes, L., Warncke, J. D., Filchenko, I., Shi, K., Bassetti, C. L. A., & Schäfer, C. (2026). Actigraphy Meets AI : A Digital Biomarker for Parkinson's Disease and Isolated REM Sleep Behaviour Disorder. Journal of Sleep Research, 35(5). https://doi.org/10.1111/jsr.70396
Vancouver
Lopes L, Warncke JD, Filchenko I, Shi K, Bassetti CLA, Schäfer C. Actigraphy Meets AI : A Digital Biomarker for Parkinson's Disease and Isolated REM Sleep Behaviour Disorder. Journal of Sleep Research. 2026;35(5). doi:10.1111/jsr.70396
BibTeX
@article{Lopes2026,
author = {Lopes, Leonor and Warncke, Jan D and Filchenko, Irina and Shi, Kuangyu and Bassetti, Claudio L A and Schäfer, Carolin},
title = {Actigraphy Meets AI : A Digital Biomarker for Parkinson's Disease and Isolated REM Sleep Behaviour Disorder},
journal = {Journal of Sleep Research},
year = {2026},
volume = {35},
number = {5},
doi = {10.1111/jsr.70396}
}
EUVIMED